Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Receivables (2020 - 2026)

IceCure Medical has reported Receivables over the past 7 years, most recently at $274000.0 for Q1 2026.

  • For Q1 2026, Receivables changed N/A year-over-year to $274000.0; the TTM value through Mar 2026 reached $274000.0, changed N/A, while the annual FY2025 figure was $331000.0, 10933.33% up from the prior year.
  • Receivables was $274000.0 for Q1 2026 at IceCure Medical, down from $331000.0 in the prior quarter.
  • Across five years, Receivables topped out at $331000.0 in Q4 2025 and bottomed at $78000.0 in Q4 2022.
  • The 5-year median for Receivables is $221000.0 (2024), against an average of $201400.0.
  • Year-over-year, Receivables plummeted 82.89% in 2022 and then skyrocketed 114.56% in 2024.
  • Over 5 years, Receivables stood at $78000.0 in 2022, then soared by 32.05% to $103000.0 in 2023, then skyrocketed by 114.56% to $221000.0 in 2024, then skyrocketed by 49.77% to $331000.0 in 2025, then fell by 17.22% to $274000.0 in 2026.
  • The last three reported values for Receivables were $274000.0 (Q1 2026), $331000.0 (Q4 2025), and $221000.0 (Q4 2024) per Business Quant data.